Program for the Promotion of Physical Exercise and Healthy Eating Among Population of Pakistani Origin With Obesity
PEFAS
1 other identifier
interventional
60
1 country
1
Brief Summary
This randomized control trial aims to evaluate the effectiveness of a culturally and linguistically adapted nutrition education and physical exercise program on lifestyle (diet and exercise), metabolic parameters, and fat content and distribution of people of Pakistani origin with obesity residing in the North Metropolitan health area of Barcelona. The betterment of the mentioned parameters is expected to be greater in individuals from the intervention group who will receive a total of 12 sessions of nutrition education and physical exercise compared to the control group who will participate in only 4 sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable obesity
Started Mar 2024
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2024
CompletedFirst Submitted
Initial submission to the registry
November 29, 2024
CompletedFirst Posted
Study publicly available on registry
June 6, 2025
CompletedJune 6, 2025
May 1, 2025
8 months
November 29, 2024
May 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (18)
Fat mass and total body mass measured by bioimpedance analysis
Body fat mass and total body mass will be quantified using bioimpedanciometry
Baseline, 3 months and 6 months
Thickness of superficial and pre-peritoneal fat (mm) measured by ultrasound of the rectus abdominis
Subcutaneous and pre-peritoneal fat thickness will be assessed using ultrasound imaging of the rectus abdominis muscle.
Baseline, 3 months, and 6 months
Quadriceps muscle thickness (mm) measured by ultrasound
Muscle mass will be evaluated through ultrasound measurements of the quadriceps muscl
Baseline, 3 months, and 6 months
Body Mass Index (BMI) in kg/m²
BMI will be calculated as weight in kilograms divided by height in meters squared (BMI = kg/m²). Weight will be measured using a calibrated digital scale, and height will be measured with a portable stadiometer.
Baseline, 3 months, and 6 months
Waist circumference (cm)
Waist circumference will be measured at the midpoint between the lowest rib and the iliac crest using non-stretchable tape, recorded to the nearest 0.1 cm with the participant standing.
Baseline, 3 months, and 6 months
Physical exercise
The information related to the physical exercise will be gathered through the validated Urdu version of the International Physical Activity Questionnaire (IPAQ). Results will be reported as a continuous variable (MET minutes a week). Furthermore, participants from both the control and the intervention group will be provided with a smartwatch that will register their daily physical activity. The results will be presented in total minutes of intense and moderate physical activity per week.
Baseline, 3 months and 6 months
Health-related quality of life
Perceived physical and mental health will be assessed using the 12-Item Short Form Survey (SF-12). The SF-12 is a self-reported outcome measure of health-related quality of life, widely used in various ethnic groups. It consists of 12 questions that are scored in various ways. The total score range is 12-47 (higher scores mean a worse outcome).
Baseline, 3 months and 6 months
Fasting glucose level (mg/dL)
Fasting glucose will be measured in serum samples using enzymatic methods.
Baseline, 3 months, and 6 months
Hemoglobin A1C (%)
HbA1c will be measured from whole blood using high-performance liquid chromatography (HPLC).
Baseline, 3 months, and 6 months
Insulin (mIU/L)
Fasting insulin concentration will be measured using electrochemiluminescence immunoassay.
Baseline, 3 months, and 6 months
Aspartate aminotransferase (AST)(UI/L)
AST will be measured via kinetic UV test using an automated analyzer.
Baseline, 3 months, 6 months
Alanine aminotransferase (ALT)(UI/L)
ALT will be measured via kinetic UV test using an automated analyzer.
Baseline, 3 months, 6 months
Gamma-glutamyl transferase (GGT)(UI/L)
GGT will be measured using enzymatic colorimetric methods.
Baseline, 3 months, 6 months
Total cholesterol (mg/dL)
Total cholesterol will be measured using enzymatic colorimetric methods.
Baseline, 3 months, 6 months
LDL cholesterol (mg/dL)
LDL-C will be measured directly via homogenous enzymatic assay.
Baseline, 3 months, 6 months
HDL cholesterol (mg/dL)
HDL-C will be measured directly via homogenous enzymatic assay.
Baseline, 3 months, 6 months
Adherence to Mediterranean Diet using modified MEDAS questionnaire
Adherence to the Mediterranean Diet will be assessed using a modified version of the 14-item Mediterranean Diet Adherence Screener (MEDAS), excluding the alcohol intake item (13 items total). Scores range from 0 to 13, with higher scores indicating better adherence. A score \< 9 indicates low adherence; ≥ 9 indicates good adherence.. Unit of measure: score 0-13
Baseline, 3 months, 6 months
Nutrient intake measured by 24-hour Dietary Recall
Nutrient and food group intake will be assessed using a structured 24-hour Dietary Recall (24HR), administered by trained staff. Data will be analyzed using nutritional analysis software to estimate daily intake. Unit of measure: grams, Kcal
Baseline, 3 months, 6 months
Secondary Outcomes (10)
Sociodemographic data
Baseline
Clinical history
Baseline
Toxic habits
Baseline, 3 months and 6 months
Nutrition knowledge
Baseline, 3 months and 6 months
Nutrition skills
Baseline, 3 months and 6 months
- +5 more secondary outcomes
Study Arms (2)
Active
ACTIVE COMPARATORLife-style interventions (diet and exercise)
Control
OTHERUsual care
Interventions
A 6-week intensive randomized controlled trial will be conducted with a total of 60 participants. Thirty participants will be assigned to the intervention group and thirty to the control group through simple randomization using a table of random numbers. The intervention group will receive one weekly theoretical-practical nutrition education session in Urdu and one physical activity session based on Nordic walking per week, for a total of six nutrition sessions and six physical activity sessions over the 6-week period.
The control group will participate in 2 theoretical sessions of nutrition education and 2 of physical exercise.
Eligibility Criteria
You may qualify if:
- Being of Pakistani origin
- Being Aged over 18 years
- Having obesity, defined as BMI ≥ 27 Kg/m2
- Being attended at the Saint Roc or Gorg Primary Care Centers, Endocrinology and Nutrition External Consultations at the Germans Trias i Pujol University Hospital (HUGTiP) or at the Specialized Care Center (Dr. Barraquer in St. Adrià and Dr. Robert in Badalona)
- Voluntarily accepting participation in the study.
You may not qualify if:
- Presenting a physical or mental illness that could prevent participation in the study.
- Presenting any pathology that could limit life expectancy in the short term.
- Pregnancy.
- Having a close family member included in the project.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, 08916, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Maria-Teresa Julian, MD
Hospital Universitario Germans Trias i Pujol (Badalona)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 29, 2024
First Posted
June 6, 2025
Study Start
March 3, 2024
Primary Completion
October 30, 2024
Study Completion
October 30, 2024
Last Updated
June 6, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share